Venus Medtech (Hangzhou) (HKSE:02500) EV-to-EBITDA : -4.22 (As of May. 26, 2024)

Venus Medtech (Hangzhou) EV-to-EBITDA Chart

Venus Medtech (Hangzhou) Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial							-24.27	-	-4.68	-	-4.22

Competitive Comparison of Venus Medtech (Hangzhou)'s EV-to-EBITDA

For the Medical Devices subindustry, Venus Medtech (Hangzhou)'s EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Medtech (Hangzhou)'s EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Medtech (Hangzhou)'s EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Venus Medtech (Hangzhou)'s EV-to-EBITDA falls into.

Venus Medtech (Hangzhou) EV-to-EBITDA Calculation

Venus Medtech (Hangzhou)'s EV-to-EBITDA for today is calculated as:

Venus Medtech (Hangzhou)'s current Enterprise Value is HK$2,527.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Venus Medtech (Hangzhou)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-599.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Venus Medtech (Hangzhou)  (HKSE:02500) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Venus Medtech (Hangzhou)'s PE Ratio for today is calculated as:

Venus Medtech (Hangzhou)'s share price for today is HK$5.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Venus Medtech (Hangzhou)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-1.761.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Venus Medtech (Hangzhou) EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Medtech (Hangzhou) (HKSE:02500) Business Description